A Sharing Tool For Next-Gen Sequencing: FDA Launches precisionFDA
This article was originally published in The Gray Sheet
Executive Summary
As scheduled, FDA has launched its precisonFDA portal that the agency says will aggregate research data to help develop and verify next generation sequencing diagnostic tests.
You may also be interested in...
'App-A-Thon' Aims To Create PrecisionFDA Software Library To Advance Next-Gen Sequencing
US FDA is challenging stakeholders to develop apps that users of its precisionFDA platform can leverage to advance next-generation sequencing technology. Results from the competition will be announced by Commissioner Robert Califf next month in Washington, DC.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.